Haploidentical Stem Cell Transplantation An Emerging Treatment Modality /
| Autor Corporativo: | |
|---|---|
| Otros Autores: | |
| Formato: | eBook |
| Lenguaje: | English |
| Publicado: |
Cham :
Springer International Publishing : Imprint: Humana,
2017.
|
| Edición: | 1st ed. 2017. |
| Colección: | Stem Cell Biology and Regenerative Medicine,
|
| Materias: | |
| Acceso en línea: | https://doi.org/10.1007/978-3-319-65319-8 |
Tabla de Contenidos:
- 1. General Indications and Logic for Haploidentical SCT
- 2. Donor Selection and Cell Dose in Haploidentical SCT
- 3. Graft Failure and Rejection in Haploidentical SCT
- 4. Toxicity of Conditioning Regimens in Haploidentical SCT
- 4. Toxicity of Conditioning Regimens in Haploidentical SCT
- 5. An Overview of the Prophylaxis and Treatment of GVHD in Haploidentical STC
- 6. Prevention and Treatment of Infectious Complications in Haploidentical SCT
- 7. Graft versus Leukemia (GVL), Graft versus Lymphoma Effect in Haploidentical SCT
- 8. Outcome of Haploidentical SCT in Patients with Acute Leukemia
- 9. Outcome of Haploidentical SCT in Patients with Lymphoma
- 10. Applications of Haploidentical SCT in Patients with Non-malignant Diseases
- 11. Applications of Haploidentical SCT in Pediatric Patients
- 12. Innovative Approaches in Order to Increase the Success of the Haploidentical SCT. 13. Future Perspectives for Haploidentical SCT.